Of 10 patients evaluated, 9 had somatic mutations in both tumor and ascites ctDNA, with the most common mutated gene being TP53; thus ascites ctDNA was felt to be helpful in identifying the mutational landscape of ovarian cancer [98]. This evidence concerns the gene TP53 and neoplasm.